opioid News & Analysis

Albertsons (ACI) Reports Sales Miss and $774M Settlement Impact

Albertsons (ACI) reported a sales miss and a downbeat outlook, attributing this to slower GLP-1 growth and higher gas prices. Additionally, the company announced a $774 million settlement related to opioid claims. This news has led to a decline in the stock price as investors react to the combination of disappointing sales performance and financial liabilities. The settlement adds significant liabilities, potentially affecting future profitability and stock market performance.